Recruiting Antiphospholipid Syndrome Studies in Philadelphia
About Antiphospholipid Syndrome Clinical Trials in Philadelphia
Antiphospholipid syndrome is an autoimmune disorder that increases the risk of blood clots in arteries and veins, and pregnancy complications. It occurs when the immune system makes antibodies that attack phospholipids. Treatment primarily involves anticoagulant medications.
There are currently 8 antiphospholipid syndrome clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 788 participants. Research is being sponsored by NICHD Pelvic Floor Disorders Network, Janssen Research & Development, LLC, Chugai Pharmaceutical and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Antiphospholipid Syndrome Clinical Trials in Philadelphia — FAQ
Are there antiphospholipid syndrome clinical trials in Philadelphia?
Yes, there are 8 antiphospholipid syndrome clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What antiphospholipid syndrome treatments are being tested?
The 8 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for antiphospholipid syndrome.
Data updated July 13, 2026 from ClinicalTrials.gov